Oncogene

Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer.

Oncogene

Peyser ND, Freilino M, Wang L, Zeng Y, Li H, Johnson DE, Grandis JR

Oncogenic activation of the PI3-kinase p110ß isoform via the tumor-derived PIK3Cß(D1067V) kinase domain mutation.

Oncogene

Pazarentzos E, Giannikopoulos P, Hrustanovic G, St John J, Olivas VR, Gubens MA, Balassanian R, Weissman J, Polkinghorn W, Bivona TG

Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer.

Oncogene

Peyser ND, Freilino M, Wang L, Zeng Y, Li H, Johnson DE, Grandis JR

Oncogenic activation of the PI3-kinase p110ß isoform via the tumor-derived PIK3Cß(D1067V) kinase domain mutation.

Oncogene

Pazarentzos E, Giannikopoulos P, Hrustanovic G, St John J, Olivas VR, Gubens MA, Balassanian R, Weissman J, Polkinghorn W, Bivona TG

Adaptive stress signaling in targeted cancer therapy resistance.

Oncogene

Pazarentzos E, Bivona TG

Adaptive stress signaling in targeted cancer therapy resistance.

Oncogene

Pazarentzos E, Bivona TG

Targeting HER3 by interfering with its Sec61-mediated cotranslational insertion into the endoplasmic reticulum.

Oncogene

Ruiz-Saenz A, Sandhu M, Carrasco Y, Maglathlin RL, Taunton J, Moasser MM

Targeting HER3 by interfering with its Sec61-mediated cotranslational insertion into the endoplasmic reticulum.

Oncogene

Ruiz-Saenz A, Sandhu M, Carrasco Y, Maglathlin RL, Taunton J, Moasser MM

Alternative splicing in cancer: implications for biology and therapy.

Oncogene

Chen J, Weiss WA

Alternative splicing in cancer: implications for biology and therapy.

Oncogene

Chen J, Weiss WA

Pages